Skip to main content

Table 1 Characteristics of Study Participants at Baseline

From: Randomized pilot trial of a synbiotic dietary supplement in chronic HIV-1 infection

Characteristic

Fiber only Group

Synbiotic Group

Gender, N (%)

  

Female

13 (100)

14 (100)

Male

none

none

Race/Ethnicity, self described

  

African American, N (%)

6 (46.2)

7 (42.9)

Caucasian, N (%)

5 (38.5)

6 (50.0)

Other, N (%)

2 (15.4)

1 (7.1)

Mean age, years (SD)

48.8 (6.1)

46.4 (8.0)

Years HIV seropositive, Mean (SD)

12.3 (6.8)

15.2 (8.6)

Years on antiretroviral therapy, Mean (SD)

7.0 (4.7)

8.7 (5.5)

Blood CD4 count, cells/μl, Mean (SD)

588 (309)

685 (249)

Viral load <50 copies/ml, N (%)

9 (69.2)

12 (85.7)

Viral load >50 copies/ml, N (Geometric Mean, SD)

4 (581, 6257)

2 (83, 1.4)

Cultured foods consumption. Mean servings/week (SD)

5.3 (4.1)

6.1 (5.4)